Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 10/20 | 0.46 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5672145 | 0.93 | LMNA (0.52) | LMNAMAPTCYP19A1NR3C1CYP3A4 | |
| SCHEMBL7877720 | 0.93 | LMNA (0.52) | LMNAMAPTCYP19A1NR3C1CYP3A4 | |
| SCHEMBL18662883 | 0.91 | LMNA (0.52) | LMNAMAPTCYP19A1NR3C1CYP3A4 | |
| SCHEMBL15994233 | 0.90 | LMNA (0.51) | LMNAMAPTCYP19A1NR3C1CYP3A4 | |
| SCHEMBL2831630 | 0.85 | LMNA (0.51) | LMNAMAPTCYP19A1NR3C1CYP3A4 | |
| SCHEMBL8587966 | 0.84 | LMNA (0.54) | LMNAMAPTCYP19A1NR3C1CYP3A4 | |
| SCHEMBL1847854 | 0.83 | LMNA (0.44) | LMNAMAPTCYP19A1NR3C1CYP3A4 | |
| SCHEMBL8661015 | 0.83 | LMNA (0.44) | LMNAMAPTCYP19A1NR3C1CYP3A4 | |
| SCHEMBL6521590 | 0.83 | LMNA (0.44) | LMNAMAPTCYP19A1NR3C1CYP3A4 | |
| SCHEMBL3399652 | 0.83 | LMNA (0.51) | LMNAMAPTCYP19A1NR3C1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8944055-B2 | Inhaler | VECTURA DELIVERY DEVICES LIMITED (GB) | 2015-02-03 | — | — | US | disclosed |
| US-20110048420-A1 | INHALER | VECTURA DELIVERY DEVICES LIMITED (GB) | 2011-03-03 | — | — | US | disclosed |
| EP-2244770-A1 | INHALER | Vectura Delivery Devices Limited (GB) | 2010-11-03 | — | — | EP | disclosed |
| EP-2178586-A2 | INHALER | Vectura Delivery Devices Limited (GB) | 2010-04-28 | — | — | EP | disclosed |
| EP-2178587-A2 | INHALER | Vectura Delivery Devices Limited (GB) | 2010-04-28 | — | — | EP | disclosed |
| US-20090229608-A1 | Inhaler | VENTURA DELIVERY DEVICES LIMITED (GB) | 2009-09-17 | — | — | US | disclosed |
| EP-2082766-A1 | Blister Strip Coil Forming | Vectura Delivery Devices Limited (GB) | 2009-07-29 | — | — | EP | disclosed |
| EP-2044099-A2 | PROCESS FOR THE PREPARATION OF S-FLUOROMETHYL-6 ,9 -DIFLUORO-11 -HYDROXY-16 -METHYL-17 -PROPIONYLOXY-3-OXO-ANDROSTA-1,4-DIENE-17 -CARBOTHIOATE AND INTERMEDIATES | Merck Generics (UK) Limited (GB) | 2009-04-08 | — | — | EP | disclosed |
| EP-2031965-A2 | NOVEL COMPOUNDS | Glaxo Group Limited (GB) | 2009-03-11 | — | — | EP | disclosed |
| EP-2032142-A2 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2009-03-11 | — | — | EP | disclosed |
| EP-1879579-A1 | INHALATION DEVICE CONTAINING PLURAL DOSES OF A PHARMACEUTICAL COMPOSITION | Boehringer Ingelheim International GmbH (DE) | 2008-01-23 | — | — | EP | disclosed |
| WO-2007147104-A2 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007147109-A2 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007144668-A2 | PROCESS FOR THE PREPARATION OF S-FLUOROMETHYL-6, 9 -DIFLUORO-11 -HYDROXY-16 -METHYL-17-PROPIONYLOXY-3-OXO-ANDROSTA-1,4-DIENE-17 -CARBOTHIOATE AND INTERMEDIATES | GENERICS [UK] LIMITED (GB) | 2007-12-21 | — | — | WO | disclosed |
| WO-2006134021-A2 | PROCESS FOR PREPARING TIOTROPIUM SALTS, TIOTROPIUM SALTS AS SUCH AND PHARMACEUTICAL COMPOSITIONS THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-12-21 | — | — | WO | disclosed |
| WO-2006117353-A1 | INHALATION DEVICE CONTAINING PLURAL DOSES OF A PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-11-09 | — | — | WO | disclosed |
| EP-1611149-A1 | PROCESS FOR THE PREPARATION OF STEROIDAL CARBOTHIOIC ACID DERIVATIVES AND INTERMEDIATES | Alpharma APS (DK) | 2006-01-04 | — | — | EP | disclosed |
| EP-1534733-A2 | CONVENIENT SYNTHESIS OF S-FLUOROMETHYL 6ALPHA, 9ALPHA-DIFLUORO-11BETA-HYDROXY-16ALPHA- METHYL-17ALPHA-PROPIONYLOXY-3-OXOANDROSTA-1, 4-DIENE-17BETA-CARBOTHIOATE | Sun Pharmaceuticals Industries Ltd. (IN) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004087731-A1 | PROCESS FOR THE PREPARATION OF STEROIDAL CARBOTHIOIC ACID DERIVATIVES AND INTERMEDIATES | ALPHARMA APS (DK) | 2004-10-14 | — | — | WO | disclosed |
| WO-2004001369-A2 | CONVENIENT SYNTHESIS OF S-FLUOROMETHYL 6ALPHA, 9ALPHA-DIFLUORO-11BETA-HYDROXY-16ALPHA- METHYL-17ALPHA-PROPIONYLOXY-3-OXOANDROSTA-1, 4-DIENE-17BETA-CARBOTHIOATE | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2003-12-31 | — | — | WO | disclosed |